Bayer’s healthcare division generated more than 20 percent of 2009 sales in the Asia Pacific region, where it saw faster growth than in any other region. While it is one of the largest pharmaceuticals suppliers in China, its presence in the Indian drug market has been of little significance. “In India we are open to businesses to strengthen our position,” Bayer Asia Pacific (prescription drug) incharge Alok Kanti said, adding that the company was “looking for the right opportunity and evaluating every opportunity.” Bayer’s business in India has so far been dominated by its CropScience pesticides unit.
(Published 12 March 2010, 16:05 IST)
JOIN US